From Name:
From Email:
To Name:
To Email:

Optional Message:


Novartis, Pear collaborating on digital therapeutics to treat MS, schizophrenia

from Multiplesclerosis News Today

Novartis and Pear Therapeutics are joining forces to develop novel prescription digital therapeutics to treat patients with schizophrenia and multiple sclerosis (MS). Digital therapeutics are software applications designed to treat diseases and improve clinical outcomes for patients. Combining Novartis’ expertise in biomedical research and clinical development with Pear’s knowledge in digital therapeutics will allow the companies to create these innovative treatment tools. more


Powered by MultiBriefs
7701 Las Colinas Blvd., Ste. 800, Irving, TX 75063